MUMBAI, India, July 30 -- Intellectual Property India has published a patent application (202641089032 A) filed by Vellore Institute Of Technology on July 21, 2026, for System And Method For Blockchain-Based Pharmaceutical Batch Integrity Monitoring Using Evidence-Weighted Risk Evaluation.
Inventors include Priya G; and Debarati.
The application for the patent was published on July 24, 2026, under issue no. 30/2026.
Abstract: ABSTRACT SYSTEM AND METHOD FOR BLOCKCHAIN-BASED PHARMACEUTICAL BATCH INTEGRITY MONITORING USING EVIDENCE- WEIGHTED RISK EVALUATION A computer-implemented method for monitoring pharmaceutical batch integrity using a distributed ledger network is disclosed. The method includes receiving, by a risk assessment engine, batch data associated with a pharmaceutical batch from supply-chain participants registered on the distributed ledger network. The method includes computing a custody consistency score, an evidence completeness score, a cold-chain compliance score, a delivery consistency score, and a participant reliability score. The method includes calculating a Batch Integrity Risk Index (BIRI) value based on a weighted combination of the component scores. The method includes classifying, by a decision module, the pharmaceutical batch into a Release category, a Warning category, or a Quarantine category based on the BIRI value. The method includes recording, by a smart contract executing on the distributed ledger network, the BIRI value and the decision category. Evidence records may be stored in a decentralized storage system off-chain with content identifiers recorded on-chain. A tamper-evident audit trail comprising batch registration data, evidence submission records, custody transfer records, the BIRI value, and the decision category may be generated and stored on the distributed ledger network.
Disclaimer: Curated by HT Syndication.
